Moreover, such IgA1 ACPA levels were shown to decline in follow-up samples closer to RA onset, suggesting that these autoantibodies may transit to the joint (or other tissues) in conjunction with disease development. The gene discussed is IGHA1; the disease is rheumatoid arthritis.